Previous Close | 24.10 |
Open | 24.10 |
Bid | 22.85 |
Ask | 25.95 |
Strike | 60.00 |
Expire Date | 2024-08-16 |
Day's Range | 24.10 - 24.10 |
Contract Range | N/A |
Volume | |
Open Interest | 5 |
Female-specific results from first-of-its-kind clinical trial NORTHAMPTON, MA / ACCESSWIRE / May 1, 2024 / Teaching first graders takes a lot of energy. So when Julia Garcia started feeling worn out, teaching became extremely difficult. "I got very ...
Medtronic (MDT) closed at $80.86 in the latest trading session, marking a +1.4% move from the prior day.
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.